A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension
NCT00219050
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
aliskiren
Sponsor
Novartis